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Summary
Rab6 is a conserved small GTPase that localizes to the Golgi
apparatus and cytoplasmic vesicles and controls transport
and fusion of secretory carriers [1]. Another Rab implicated
in trafficking from the trans-Golgi to the plasma membrane is
Rab8 [2–5]. Here we show that Rab8A stably associates with
exocytotic vesicles inaRab6-dependentmanner.Rab8A func-
tion isnot needed forbuddingormotilityof exocytotic carriers
but is required for their docking and fusion. These processes
also depend on the Rab6-interacting cortical factor ELKS [1],
suggesting that Rab8A and ELKS act in the same pathway.
We show that Rab8A and ELKS can be linked by MICAL3,
a member of the MICAL family of flavoprotein monooxyge-
nases [6]. Expression of a MICAL3 mutant with an inactive
monooxygenase domain resulted in a strong accumulation
of secretory vesicles that were docked at the cell cortex but
failed to fuse with the plasma membrane, an effect that corre-
lated with the strongly reduced mobility of MICAL3. We pro-
pose that the monooxygenase activity of MICAL3 is required
to regulate its own turnover and the concomitant remodeling
of vesicle-docking protein complexes in which it is engaged.
Taken together, the results of our study illustrate cooperation
of two Rab proteins in constitutive exocytosis and implicates
a redox enzyme in this process.
Results and Discussion
Small GTPase Rab6 is associated with the Golgi complex and
cytoplasmic vesicles; it is represented in mammals by Rab6A8These authors contributed equally to this work
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*Correspondence: a.akhmanova@uu.nland Rab6A0, which are ubiquitously expressed and will be
collectively called Rab6 here when referring to the endoge-
nous protein, and the neuronal isoform Rab6B [7–10]. In non-
polarized cells such as HeLa, the majority of Rab6 vesicles
are constitutive secretion carriers [1]. Because Rab8 has also
been implicated in secretory traffic [2–5], we tested whether
endogenous Rab6 and Rab8A colocalize on the same vesicles
and found that this was indeed the case (Figures 1A and 1B).
Rab8A-positive vesicles are exocytotic carriers because they
contain the secretion marker neuropeptide Y (NPY)-Venus
[1, 11] (Figure 1C). In addition, antibodies against Rab8A
weakly stain the Golgi region and strongly decorate tubules,
which show strong variability in size and abundance and likely
represent an endosomal compartment [5, 12]. These tubules
were devoid of endogenous Rab6 or NPY-Venus (arrows in
Figures 1A and 1L; Figure 2E).
Next, we analyzed Rab6A-Rab8A colocalization by live
imaging and found a high degree of overlap between the two
markers on vesicles (Figures 1D and 1E). Colocalization of
the two Rabs on moving vesicles was observed from the
moment the vesicles left the Golgi area (Figure 1H; see also
Figures S1A and S1B available online). Similar results were
obtained in other cell lines, such asMRC5-SV (data not shown)
and hTert-RPE1 (Figures S1C and S1D). Importantly, in serum-
starved hTert-RPE1 cells, mStrawberry-Rab8A strongly accu-
mulated in the primary cilia, in line with the published data [13],
whereas GFP-Rab6 was not enriched in cilia (Figure S1C).
To investigate at which point Rab8A was recruited to secre-
tory vesicles, we used Rab8A fused to photoactivatable GFP
[14] (PAGFP-Rab8A) in combination with the Golgi marker
mCherry-galactosyl transferase (GT) or mStrawberry-Rab6A.
When PAGFP-Rab8A was photoactivated in the Golgi area,
we observed weak fluorescence of the Golgi stacks and bright
vesicles that rapidlymoved away from theGolgimembranes to
the cell periphery (Figures 1F and 1G; Movie S1). These vesi-
cles were positive for mStrawberry-Rab6 (data not shown).
Photoactivation of other cell regions visualized PAGFP-
Rab8A-labeled vesicles that moved to the cell periphery where
they disappeared (Movie S2). PAGFP-Rab8A-positive but
Rab6A-negative tubular structures were also present in
some cells (Movie S2); importantly, we never observed fusion
of such structures to Rab6A-positive vesicles.
Using fluorescence recovery after photobleaching (FRAP)
assay, we have shown that Rab6A does not significantly
exchange on exocytotic vesicles [1], and we found that the
same was true for Rab8A (Figure S1E and S1F). In line with
this result, when PAGFP-Rab8A was photoactivated on vesi-
cles, no significant fluorescence loss was observed within
30 s (Figures 1I and 1J), which is approximately one-third of
thew100 s duration of the exocytotic vesicle life cycle.
Next, we examined Rab8A behavior in the vicinity of the
plasmamembrane by using dual-color live total internal reflec-
tion fluorescencemicroscopy (TIRFM). Before PAGFP-Rab8A/
mStrawberry-Rab6A double-positive vesicles disappeared,
they displayed a simultaneous increase of the green and red
fluorescence followed by lateral diffusion of the two markers,
as expected for a plasmamembrane fusion event [15] (Figures
1I and 1K; Movie S2). Taken together, our data show that
Figure 1. Rab8A Binds to Exocytotic Carriers in a Rab6-Dependent Manner
(A) HeLa cells were stained for endogenous Rab6 and Rab8A.
(B, E, and H) Quantification of colocalization of Rab6 and Rab8A in HeLa cells. (B) Colocalization of endogenous Rab6 and Rab8; note that because of the
relatively high cytosolic Rab8A background, it was difficult to distinguish weak vesicular Rab8A staining, and the numbers for the endogenous proteins likely
represent an underestimate. (E and H) Colocalization of Rab6A and Rab8A in live-cell images on vesicles in cell lamella or exiting the Golgi, respectively.
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969Rab8A is present on Rab6-negative membrane compart-
ments, such as cytoplasmic tubules and cilia, and Rab6-posi-
tive exocytotic vesicles. Rab8A is loaded on these vesicles
during or soon after their exit from the Golgi and displays little
turnover until the vesicles fuse with the plasma membrane.
Rab6 depletion alters the behavior of exocytotic carriers but
does not prevent their formation [1]. Interestingly, although
Rab6 knockdown had no effect on Rab8A expression (Fig-
ure S1G), it caused a complete loss of both endogenous and
fluorescently tagged Rab8A from NPY-Venus-positive exocy-
totic vesicles (Figure 1L; Figure S1H). We conclude that Rab6
is required for Rab8A recruitment to the secretory vesicle
membrane. We have tested whether this was due to a direct
interaction between Rab6 and Rab8 GEFs Rabin3/Rabin8
andRabin3-like/GRAB [16, 17] but found no evidence support-
ing this idea (data not shown).
Next, we investigated whether the interference with Rab8A
functionbyexpressingRab8mutantswouldaffect thebehavior
of Rab6 vesicles. Whereas overexpression of the GTP-bound
Rab8A-Q67L caused a slight decrease in the number of endog-
enous Rab6 vesicles, the expression of GDP-bound Rab8A-
T22N caused a strong increase in vesicle number at the cell
margin (Figures 2A–2C and 2G). A small interfering RNA
(siRNA)-mediated depletion of Rab8A also caused an increase
in the number of vesicles (Figures 2D and 2G) without affecting
Rab6 expression (Figure S1G). Peripherally accumulated Rab6
vesicles contained exocytotic marker NPY-Venus (Figure 2D),
indicating that Rab6 recruitment to secretory vesicles is
Rab8A independent. Thespecificity of theeffect ofRab8deple-
tion could be confirmed by rescue with low-level expression of
the GFP-Rab8A insensitive to the siRNAs used (Figure S2A).
To confirm the involvement of Rab8A in constitutive secre-
tion, we used a flow cytometry-based assay [18], which
employs a secretedGFP-tagged reporter protein that is aggre-
gated and retained in the endoplasmic reticulum (ER) but
becomes soluble and is rapidly secreted when a cell-perme-
able ligand is added. Using this assay, we observed a relatively
mild but significant secretion delay in Rab8A-depleted cells
and a stronger secretion defect in Rab6-depleted cells (Fig-
ure 2F). The latter was possibly due to defects in Golgi function
and/or vesicle fission [19].
Using HeLa cells stably expressing GFP-Rab6A [1], we
found that interference with Rab8A function had no significant
effect on the frequency of emergence of GFP-Rab6A vesicles
from the Golgi, or on their movement (Figures S2B–S2D). In
contrast, whereas in control cells, Rab6 vesicles underwent
rapid docking followed by fusion with the plasma membrane,
which occurred within w30 s after initial immobilization, inLeft bar, Rab6 vesicles showing strong Rab8A labeling; right bar, Rab8A vesicle
Rab6/Rab8A, 1234 vesicles in 15 cells; Rab6A/Rab8A vesicles in lamella, 739
7 cells.
(C) HeLa cells, stably expressing NPY-Venus, were stained for endogenous Ra
(D) Representative frames of a simultaneous two-color movie, showing the pe
(F and G) Frames from a simultaneous two-color movie, showing the Golgi ar
The area indicated with a stippled line was photoactivated using a 408 nm laser
at different time points after photoactivation are shown. See also Movie S1.
(I) Frames from a TIRFM movie showing the behavior of a single PAGFP-Rab8
fusion. Time after photoactivation (performed in peripheral cytoplasm using a
(J) Plot of the average fluorescent intensity ofmoving PAGFP-Rab8A vesicles af
disk microscope. Linescan (line thickness 0.32 mm) was applied to measure pix
(K) Plot of average fluorescence intensity of a single PAGFP-Rab8A- andmStraw
Vesicle appearance in the focal plane is indicated by a vertical arrow. The hori
vesicle fusion with the plasma membrane.
(L) HeLa cells stably expressing NPY-Venus were transfected with the indicate
transfection. In (A), (B), and (L), insets show enlargements of the boxed areas.Rab8A-depleted cells, GFP-Rab6A vesicles underwent diffu-
sive movements at the cell margin, and the duration of the
pause between final immobilization and actual fusion with
plasma membrane (terminal pause) was strongly increased
(Figure 2H; Figures S2E, S2F, and S2H). Previously, we
observed a similar defect in docking and fusion of Rab6 vesi-
cles in cells depleted of the cortical Rab6-interacting coiled-
coil protein ELKS (also known as ERC1, CAST2, or Rab6IP2)
[1, 20]. Using ELKS siRNA, we showed that ELKS is not
required for Rab8A recruitment to Rab6 vesicles (Figure 2E).
Furthermore, we confirmed our previous results showing that
ELKS had no effect on Rab6 vesicle emergence from the Golgi
or their microtubule-based movement (Figures S2B–S2D) but
was needed for their proper docking and fusion (Figure 2H;
Figures S2F and S2H) and caused a reduction in secretion
efficiency similar to Rab8A depletion (Figure 2F).
Our results suggest that Rab8A and ELKS might work in the
same pathway. We could detect no significant pool of ELKS on
the vesicles (data not shown). Instead, ELKS localized to
patches at the cell cortex, and these patches served as sites
for preferential docking and fusion of Rab6 vesicles [1, 21].
In Rab8A-depleted cells, Rab6 vesicles preferentially accumu-
lated in regions devoid of cortical ELKS (Figure S2I), indicating
that Rab8A might contribute to vesicle interaction with ELKS-
positive sites at the plasma membrane. However, we could
find no strong evidence for a direct binding between Rab8A
and ELKS (data not shown).
To search for proteins that could link Rab8A and ELKS, we
performed pull-down assays with biotinylation and GFP-
tagged (BioGFP) ELKS (Figure S3A) and analyzed the resulting
proteins by mass spectrometry. One of the most significant
hits was MICAL3 (Figures S3B and S3C), a member of the
MICAL family of flavoprotein monooxygenases implicated in
axon guidance and actin remodeling [6, 22, 23]. MICALs,
encoded in mammals by three genes, are large proteins,
which, in addition to the monooxygenase enzymatic domain,
include an actin-binding calponin homology (CH) domain, a
LIM domain, and several predicted coiled coils (Figure 3A).
There are also two MICAL-like proteins, which lack the mono-
oxygenase domain [24]. The C-terminal domains of MICAL1,
MICAL2 (MICAL-cl), and MICAL-L1/L2 were shown to interact
with Rab8A as well as some other Rabs [24, 25]. We confirmed
the Rab8A-MICAL1 binding and showed that MICAL3 also
interacts with Rab8A through its C terminus (Figure 3B), an
interaction that was previously overlooked because an
incomplete MICAL3 cDNA was tested [24].
We raised antibodies against MICAL3 and showed that the
full-length protein is expressed in HeLa cells (Figure S3D).s showing strong Rab6 labeling. Numbers of counted vesicles: endogenous
vesicles in 6 cells; Rab6A/Rab8A vesicles exiting the Golgi, 259 vesicles in
b8A.
riphery of a HeLa cell expressing GFP-Rab6A and mStrawberry-Rab8A.
ea of a HeLa cell expressing PAGFP-Rab8A (green) and mCherry-GT (red).
. Images of the whole area (F) and enlargements of the boxed area (G) taken
A and mStrawberry-Rab6A-positive vesicle immediately before and during
407 nm laser) is indicated. See also Movie S2.
ter photoactivation in the Golgi area. Imagingwas performedwith a spinning
el intensities along the vesicle path in the kymographs of individual vesicles.
berry-Rab6A-positive vesicle (a circle with a diameter of 0.65 mm) over time.
zontal arrow points to the peak of fluorescence intensity, corresponding to
d siRNA, fixed, and stained for the endogenous Rab8A 3 days after siRNA
Rab8A-positive tubules are indicated by arrows.
Figure 2. Rab8A Is Required for Docking and Fusion of Rab6 Vesicles
(A–C) HeLa cells were transfected with the indicated GFP-Rab8A fusions and stained for endogenous Rab6.
(D) HeLa cells stably expressing NPY-Venus were transfected with Rab8A siRNA, fixed 3 days later, and stained for endogenous Rab6.
(E) HeLa cells were transfected with ELKS siRNA, fixed 3 days later, and stained for endogenous Rab6 and Rab8A. Tubules positive for Rab8A and negative
for Rab6 are indicated by arrowheads. In (D) and (E), insets show enlargements of the boxed areas.
(F) Cells stably expressing the secretion reporter SS-GFP-FM4-FCS-hGH [18] were transfected with different siRNAs; 3 days later, secretion was stimulated
by the addition of 1 mMAP21998, and the average intracellular fluorescence was measured using flow cytometry at 45 and 60 min after ligand addition. The
percentage of fluorescent signal loss at 45 and 60 min compared to control (no ligand added) was determined in four independent samples for each siRNA
and each time point.
(G) Quantification of vesicles positive for endogenous Rab6 in HeLa cells fixed and stained as described for (A)–(E). At least 200 vesicles were analyzed
inw6 cells for each condition.
(H) HeLa cells stably expressing GFP-Rab6A and transfected with the indicated mStrawberry-Rab8A fusions or siRNAs were imaged using wide-field
epifluorescence microscopy, and the duration of the pause between vesicle immobilization at the cell periphery and its disappearance was measured.
One hundred vesicles in five cells were analyzed for each condition. In (F)–(H), values significantly different from control are indicated by asterisks
(*p < 0.05; **p < 0.01; Mann-Whitney U test).
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endogenous MICAL3 and ELKS (Figure 3C). In contrast, we
observed no strong interaction between ELKS and MICAL1,
a conclusion supported by pull-downs of BioGFP-MICAL1
and BioGFP-MICAL3 (Figure S3E). Furthermore, using pull-
down assays from cells expressing BioGFP-ELKS together
with different MICAL3 fragments, we mapped the ELKS-inter-
acting domain to the C-terminal portion of MICAL3 (MICAL3-
C2) that is distinct from Rab8A-binding region MICAL3-CC
(Figures 3A and 3D; Figure S3F). Using ELKS deletion mutants,we found that MICAL3- and Rab6-interacting regions on ELKS
are also distinct: the sequence between amino acids 950 and
1015 of ELKS is required for Rab6, but not for MICAL3 binding
(Figures 3E and 3G; Figure S3G).
Next, we investigated whether Rab8A, ELKS, and MICAL3
could form a triple complex in transfected cells and found
that FLAG-tagged Rab8A coprecipitated GFP-ELKSmore effi-
ciently when it was coexpressed together with GFP-MICAL3
(Figure 3F). Coprecipitation was specific for Rab8A, because
it was not observed with Rab7 (Figure S3H). We conclude
Figure 3. MICAL3 Binds to Rab8A and ELKS
(A) A scheme ofMICAL3 protein and the constructs used in this study and a summary of identified interactions (ND, not determined). The accession numbers
of the protein sequences used are indicated. The numbering is based on MICAL3 isoform 1 (NCBI protein NP_056056); compared to this sequence, the full-
length clone used in this study contains a short internal deletion that does not affect any of the conserved domains. Abbreviations for protein domains: CH,
calponin homology domain; LIM, Lin11, Isl-1, and Mec-3 domain (zinc binding); CC, predicted coiled coil. Actin disassembly was determined by phalloidin
staining in transfected cells; see Figure S4F.
(B) GST pull-down assays were performed with the indicated GST fusions and lysates of cells expressing GFP-ELKS or GFP-Rab8A. Coomassie-stained
gels are shown for GST fusions and western blots with anti-GFP antibodies for GFP fusions. Calculated molecular mass is indicated in parentheses in cases
where it is not possible to show the marker position.
(C) Immunoprecipitations (IPs) from HeLa cell extracts with control rabbit IgG or antibodies against MICAL1 or MICAL3 were analyzed by western blotting
with the indicated antibodies.
(D and E) Streptavidin pull-down assays from extracts of HEK293T cells coexpressing BirA, BioGFP, or BioGFP-ELKS and the indicated GFP-MICAL3
fusions (D) or BioGFP-MICAL3 and the indicated GFP-ELKS fusions (E). In (D), all proteins were detected with anti-GFP antibodies; in (E), BioGFP-MICAL3
was detected with anti-GFP antibodies and ELKS fusions with the antibodies against ELKS N terminus. In experiments shown in (B)–(E), 2% of the input and
10% of the precipitate was loaded on gel.
(F) IPs fromHEK293T cells coexpressing the indicated constructs using anti-FLAG antibodies. Western blotting was performedwith antibodies against GFP
or the FLAG tag. For the blots with anti-GFP antibodies, 7% of the input and 40% of the precipitate was loaded on gel; for blots with anti-FLAG antibodies,
7% of input and precipitate was loaded.
(G) A scheme of ELKS protein and the constructs used in this study and a summary of their functional properties. CC, coiled coil; Rab6 ID, Rab6 interaction
domain [20]; rescue ELKS k/d, reversal of Rab6 vesicle accumulation in ELKS-depleted cells [1].
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Figure 4. MICAL3 Is Involved in Rab6 Vesicle Fusion with the Plasma Membrane
(A) Analysis of colocalization of mCherry-MICAL3 with the indicated GFP fusions at low expression levels in live HeLa cells using TIRFM. Insets show over-
lays of the two channels, with GFP signal in green and mCherry in red.
(B) HeLa cells expressing the indicated GFP-MICAL3 fusions were fixed and stained for endogenous Rab6.
(C) Quantification of vesicles positive for endogenous Rab6 in HeLa cells as described for Figure 2G.
(D) Duration of the pause between vesicle immobilization at the cell periphery and its disappearance measured in HeLa cells stably expressing GFP-Rab6A
and transiently transfected with mCherry-MICAL3-3G3W. Analysis was performed as described for Figure 2H. In (C) and (D), values significantly different
from control are indicated by asterisks (*p < 0.05; **p < 0.01; Mann-Whitney U test).
(E) Analysis of GFP-MICAL3 and GFP-MICAL3-3G3W turnover by FRAP. The plots show processed FRAP data (green dots) and their fitting to a two-expo-
nential model (red lines); see Supplemental Experimental Procedures and Table S1 for details. Eleven or twelve cells were analyzed in three experiments. The
recovery half-times for the two components are indicated.
(F) Streptavidin pull-down assays from extracts of HEK293T cells coexpressing GFP-Rab8A, BirA, BioGFP, or the indicated BioGFP-MICAL3 fusions. All
GFP proteins were detected with anti-GFP antibodies and endogenous ELKS with antibodies against ELKS C terminus. Two percent of the input and
10% of the precipitate was loaded on gel. Calculated molecular mass is indicated in parentheses in cases where it is not possible to show the marker posi-
tion.
(G) Amodel for cooperative action of Rab6 and Rab8A in exocytosis. Rab6 promotes recruitment of Rab8A to the vesicles. Rab8A interacts with ELKS-posi-
tive cortical sites throughMICAL3, which binds to ELKS. Rab6 also contributes to vesicle interactions with the cortex through direct binding to ELKS. Redox
activity of MICAL3 promotes the docking-complex remodeling and vesicle fusion.
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ELKS. Importantly, the ELKS-N2 mutant, which can bind to
MICAL3 but not to Rab6 (Figure 3G), cannot rescue the pheno-
type of ELKS depletion [1], indicating that the direct ELKS-
Rab6 interaction appears functionally important in spite of
the existence of an additional link between ELKS and the
secretory vesicles provided by the MICAL3-Rab8 complex.Fluorescently tagged MICAL3 localized to the nucleus and
cytoplasm; it could be found on Rab8A-positive tubules, the
size and number of which increased when both MICAL3 and
Rab8A were highly overexpressed (Figure S4A). Using TIRFM
in live cells, we could clearly detect MICAL3 in ELKS-positive
patches at the cell cortex (Figure 4A). Endogenous MICAL3
was also found at the cortical patches where ELKS and its
Rab6 and Rab8 Control Constitutive Exocytosis
973cortical partner LL5b were accumulated (Figure S4B). We
observed frequent immobilization and fusion of Rab6A- and
Rab8A-labeled vesicles at the sites of cortical accumulation
of MICAL3 (Figure S4C and data not shown).
We were unable to fully deplete MICAL3 (Figure S3D), and
partial MICAL3 knockdown had no clear effect on Rab6 vesicle
behavior. As an alternative, we generated a dominant-negative
MICAL3 mutant, in which the three glycines in the FAD binding
motif GXGXXG were mutated to tryptophans (the 3G3W
mutant, Figure 3A). This triplemutation was shown to abrogate
the function of Drosophila Mical in axon guidance and actin
disassembly [22, 23]. Expression of MICAL3-3G3W, but not
the wild-type MICAL3, dramatically increased the number of
secretory vesicles positive for Rab6 and NPY-Venus (Figures
4B and 4C; Figure S4D). Live-cell imaging showed that these
vesicles underwent rapid docking and became immobilized
but failed to fuse with the plasma membrane for long time
periods (Figure 4D; Figures S2G and S4E), suggesting that
MICAL3 helps to attach Rab8-bound vesicles to the cortex,
but, without the monooxygenase activity, subsequent fusion
steps are inhibited.
The monooxygenase activity of Drosophila Mical is used to
disassemble actin filaments [23]. We overexpressed the
N-terminal part of MICAL3 and found that it strongly reduced
the amount of filamentous actin in cells, an effect that was
dependent on the intact monooxygenase domain (Figure S4F).
The expression of the full-length protein showed no strong
effect on actin, possibly as a result of autoinhibition by the
C-terminal domain [26]. It is therefore possible that during
vesicle fusion, activated MICAL3 promotes disassembly of
the cortical actin. In line with this view, MICAL3-3G3W overex-
pression caused appearance of an actin pool with slow turn-
over (Figure S4G; Table S1). However, actin disassembly by
latrunculin B did not prevent vesicle accumulation induced
by the expression of MICAL3-3G3W (data not shown). More-
over, expression of MICAL3-C1, which lacks not only the
monooxygenase activity but also the actin-binding CH domain
(Figure 3A), caused a strong vesicle accumulation similar to
that caused by MICAL3-3G3W (Figure 4C).
To explain these observations, we hypothesized that the
redox function of MICAL3 might be needed to destabilize
protein complexes in which it is engaged. In line with this
view, we found that the turnover of MICAL3 at the cell cortex
was much slower for the monooxygenase-deficient MICAL3-
3G3Wmutant as compared to the wild-type protein (Figure 4E;
Table S1). Furthermore, although MICAL3-3G3W showed
lower expression andwasmore difficult to precipitate thanMI-
CAL3-WT, it pulled down the same amount of ELKS and
a larger amount of Rab8A than the wild-type protein, suggest-
ing that its interaction with the binding partners is increased
(Figure 4F). We propose that the redox activity of MICAL3
promotes vesicle fusion by remodeling vesicle-docking
complexes in which it is engaged.
In this study, we showed that representatives of two highly
conserved Rab families, Rab6 and Rab8, cooperate in control
of exocytotic vesicle behavior. Crosstalk between different
Rabs in regulation of adjacent trafficking stages was previ-
ously demonstrated for exocytosis as well as for endosomal
Rabs [27, 28]. Here we provide an example of when two
Rabs act simultaneously on the same vesicle, but have
different functions: Rab6 controls Rab8A recruitment, vesicle
transport, and the choice of fusion sites [1], while Rab8A
promotes efficient vesicle docking and fusion, in agreement
with the role of Rab8 homolog in yeast [27]. It is possible thata system dependent on twoRabs has evolved by convergence
of two initially separate pathways, one controlling plasma
membrane fusion (Rab8) and the other regulating the emer-
gence and movement of Golgi-derived carriers (Rab6).
Participation of Rab8A in vesicle fusion with the plasma
membrane might represent its general function, which might
require interactions with actin-based motors [12, 29] or
components of vesicle tethering and fusion machinery, such
as the exocyst or SNAREs [27]. We provide evidence that
this function is also associated with binding to the MICAL-
family proteins (Figure 4G). The two mammalian MICAL-like
(MICAL-L1/L2) family members, which lack the redox activity,
were already implicated in vesicle trafficking [24, 30], and the
Mical fly gene was found as a hit in a screen for secretory
pathway components [31]. Our results suggest that the
enzymatically active MICAL proteins can participate in vesicle
tethering and fusion, most likely by monooxygenase-depen-
dent disassembly of protein complexes.
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